Sodium Nitroprusside

   
Google
 
Web NewDrugInformation.com

Sodium Nitroprusside


Drug - Sodium Nitroprusside
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Sodium Nitroprusside
Multiple ingredients are in alphabetical order.

Strength - 50MG/VIAL
The potency of the active ingredient(s), Sodium Nitroprusside. May repeat for multiple part products.

Applicant - AM PHARM PARTNERS
The firm name holding legal responsibility for Sodium Nitroprusside. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 070031
The FDA assigned number to Sodium Nitroprusside. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Sodium Nitroprusside. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 17, 1985
The date Sodium Nitroprusside was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Sodium Nitroprusside. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Sodium Nitroprusside is in. Format is RX, OTC, DISCN.

Applicant Full Name - American Pharmaceutical Partners Inc
The full name of the firm holding legal responsibility for the new application of Sodium Nitroprusside.

Sodium Nitroprusside